← Open Payments lookup

FELIX YELOVICH: Open Payments

NPI 1114090982 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,267 in 100 payments from 14 companies in 2025. Trend: 2023 $2,130 · 2024 $2,160 · 2025 $2,267

Food & beverage: $2,267
CompanyPaymentsAmount
ABBVIE INC.36$668
Janssen Biotech, Inc.23$538
Madrigal Pharmaceuticals16$348
Boston Scientific Corporation1$143
Aimmune Therapeutics, Inc.4$114
Takeda Pharmaceuticals U.S.A., Inc.4$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$81
Ardelyx, Inc.3$65
Phathom Pharmaceuticals, Inc.3$59
Gilead Sciences, Inc.3$54

Products named: TREMFYA, REZDIFFRA, RINVOQ, OverStitch Endoscopic Suturing System, SKYRIZI, CREON, ENTYVIO, ZENPEP.

Industry payments across MD — which companies pay providers there.